"I feel, like, maybe Blake [Lively] smelled his kindness -- mistook it for weakness," a storyboard artist said in a new interview.

Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s ...